1. End‐user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study
- Author
-
Montgomery, Elizabeth T, Beksinska, Mags, Mgodi, Nyaradzo, Schwartz, Jill, Weinrib, Rachel, Browne, Erica N, Mphili, Nonhlanhla, Musara, Petina, Jaggernath, Manjeetha, Ju, Susan, Smit, Jenni, Chirenje, Z Mike, Doncel, Gustavo F, and van der Straten, Ariane
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Health Sciences ,Clinical Research ,HIV/AIDS ,Clinical Trials and Supportive Activities ,Prevention ,Behavioral and Social Science ,Adolescent ,Adult ,Consumer Behavior ,Contraceptive Devices ,Female ,Cross-Over Studies ,Female ,Follow-Up Studies ,HIV Infections ,Humans ,South Africa ,Vaginal Creams ,Foams ,and Jellies ,Young Adult ,Zimbabwe ,microbicides ,PrEP ,adolescents ,women ,Public Health and Health Services ,Other Medical and Health Sciences ,Clinical sciences ,Epidemiology ,Public health - Abstract
IntroductionAdherence to HIV prevention methods is a challenge, particularly for young women in Sub-Saharan Africa. End-user research during product development can inform modifiable factors to increase future uptake and adherence.MethodsPreferences for four vaginally inserted placebo HIV prevention methods were assessed among Zimbabwean and South African young women using a crossover clinical design. For each of months 1 to 4, participants were asked to use a pre-coitally inserted film, insert (vaginal tablet) and gel once/week for a month, and a monthly ring in a randomly assigned sequence. Participants subsequently chose one preferred product to use as directed for the final study month. Women ranked the four products from most preferred to least preferred at enrolment and after trying all products.ResultsA total of 200 women aged 18 to 30 (mean 23) were enrolled; 178 (89%) completed follow-up. At baseline, 41% of participants selected the gel as their most preferred product and 61% selected the ring as least preferred. During the crossover period, most (82% to 85%) self-reported using each product at least once a week, although only half the time with sex. Objective biomarker data confirmed adequate use of all products. After trying each product, rankings changed with the film, ring, insert and gel being selected by 29%, 28%, 26% and 16% respectively. Choice varied significantly by country (p
- Published
- 2019